ATE184798T1 - Hgh enthaltende pharmazeutische zubereitungen - Google Patents

Hgh enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE184798T1
ATE184798T1 AT94920573T AT94920573T ATE184798T1 AT E184798 T1 ATE184798 T1 AT E184798T1 AT 94920573 T AT94920573 T AT 94920573T AT 94920573 T AT94920573 T AT 94920573T AT E184798 T1 ATE184798 T1 AT E184798T1
Authority
AT
Austria
Prior art keywords
pct
pharmaceutical preparations
preparations containing
containing hgh
hgh
Prior art date
Application number
AT94920573T
Other languages
English (en)
Inventor
Fabrizio Samaritani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE184798T1 publication Critical patent/ATE184798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94920573T 1994-06-17 1994-06-17 Hgh enthaltende pharmazeutische zubereitungen ATE184798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1994/000086 WO1995035116A1 (en) 1994-06-17 1994-06-17 Hgh containing pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE184798T1 true ATE184798T1 (de) 1999-10-15

Family

ID=11332180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920573T ATE184798T1 (de) 1994-06-17 1994-06-17 Hgh enthaltende pharmazeutische zubereitungen

Country Status (9)

Country Link
US (1) US5898030A (de)
EP (1) EP0804223B1 (de)
JP (1) JP3829991B2 (de)
AT (1) ATE184798T1 (de)
DE (1) DE69420872T2 (de)
DK (1) DK0804223T3 (de)
ES (1) ES2139081T3 (de)
GR (1) GR3031687T3 (de)
WO (1) WO1995035116A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
EP1064934A1 (de) 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. Gefriergetrocknete GRF-enthaltende Arzneimittel
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
CA2418960A1 (en) * 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
US7271150B2 (en) * 2001-05-14 2007-09-18 United States Of America, Represented By The Secretary, Department Of Health And Human Services Modified growth hormone
US7022333B2 (en) * 2001-10-02 2006-04-04 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US7026354B2 (en) * 2001-10-02 2006-04-11 Kimberly-Clark Worldwide, Inc. Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
JP4949828B2 (ja) * 2003-03-18 2012-06-13 アレス トレーディング ソシエテ アノニム 溶液中での成長ホルモンの安定化
FR2873695A1 (fr) * 2004-07-30 2006-02-03 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
US20060067990A1 (en) * 2004-09-30 2006-03-30 Kimberly-Clark Worldwide, Inc. Absorbent articles for inhibiting the production of exoproteins
US20060067991A1 (en) * 2004-09-30 2006-03-30 Kimberly-Clark Worldwide, Inc. Non-absorbent articles for inhibiting the production of exoproteins
CN103520735B (zh) * 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
WO2008042408A2 (en) * 2006-10-03 2008-04-10 Wyeth Lyophilization methods and apparatuses
CA2672284C (en) * 2006-12-18 2014-08-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
BR112013008103B1 (pt) 2010-09-21 2021-01-26 Ferring B.V. processo para a produção do hormônio de crescimento humano (hgh) e método para reduzir a quantidade de formas poliméricas do hgh durante um processo para a produção de hgh
EP3230309B1 (de) * 2014-12-10 2023-03-29 OPKO Biologics Ltd. Verfahren zur herstellung langwirkender ctp-modifizierter wachstumshormonpolypeptide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
EP0303746B2 (de) * 1987-08-21 1998-12-02 Mallinckrodt Group Inc. Stabilisierung von Wachstumshormonen
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
DE69232847T2 (de) * 1991-12-20 2003-09-11 Novo Nordisk A/S, Bagsvaerd Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
JPH08502021A (ja) * 1992-04-07 1996-03-05 マリンクロッド・ヴェタラネリィ・インコーポレイテッド 生体相容性ソマトトロピン溶液
DK0955062T3 (da) * 1992-07-31 2007-09-17 Genentech Inc Vandig formulering indeholdende humant væksthormon
DE60233106D1 (de) * 2001-12-19 2009-09-10 Alps Electric Co Ltd Fernsehtunereinheit

Also Published As

Publication number Publication date
JPH10504531A (ja) 1998-05-06
DE69420872D1 (de) 1999-10-28
WO1995035116A1 (en) 1995-12-28
GR3031687T3 (en) 2000-02-29
JP3829991B2 (ja) 2006-10-04
US5898030A (en) 1999-04-27
EP0804223A1 (de) 1997-11-05
EP0804223B1 (de) 1999-09-22
DK0804223T3 (da) 2000-01-24
DE69420872T2 (de) 2000-01-13
ES2139081T3 (es) 2000-02-01

Similar Documents

Publication Publication Date Title
ATE184798T1 (de) Hgh enthaltende pharmazeutische zubereitungen
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
SE8804629D0 (sv) New therapeutically active compounds
DK366889D0 (da) Peptidderivat
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
PT83872A (de) Arzneimittel
EP0564739A3 (de)
NO954320L (no) Lyosfærer omfattende gonadotropin
FI952900A0 (fi) Polypeptidi ja siitä valmistettu anti-HIV-aine
ITRM910952A1 (it) Composizioni farmaceutiche contenenti gonadotropine.
AU4536389A (en) Anti-antherosclerotic diaryl compounds
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
NO962285D0 (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
TW261605B (de)
NO952987L (no) Sårhelende blanding
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
SE9401596D0 (sv) New compounds
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
DE69011692D1 (de) Therapeutische mittel.
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
JO1711B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name